Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

KORKMAZ, T.; Seber, S.; KEFELI, U.; SARI, E.; Canhoroz, M.; OVEN, B.; YILDIRIM, E.; YASAR, N.; AYDIN, D.; BALVAN, O.; SENER, N.; YUKSEL, S.; MERT, A.; Polat, O.; Yumuk, F.; Kanat, O.; Gumus, MAHMUT; Turhal, N.

doi:10.1007/s12094-012-0960-6

Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

Atıf İçin Kopyala

KORKMAZ T., Seber S., KEFELI U., SARI E., Canhoroz M., OVEN B., ...Daha Fazla

CLINICAL & TRANSLATIONAL ONCOLOGY, cilt.15, sa.7, ss.535-540, 2013 (SCI İndekslerine Giren Dergi)

Cilt numarası: 15 Konu: 7
Basım Tarihi: 2013
Doi Numarası: 10.1007/s12094-012-0960-6
Dergi Adı: CLINICAL & TRANSLATIONAL ONCOLOGY
Sayfa Sayıları: ss.535-540

Özet

Small cell lung cancer (SCLC) has a high relapse rate despite being very chemosensitive. The efficacy of second-line treatment is dismal. Our aim was to evaluate the outcome of second-line treatment.